Company Overview - Sonim Technologies, Inc. is a leading provider of rugged mobile solutions, including phones, wireless internet data devices, accessories, and software designed for durability in demanding environments [3] - The company has been trusted by first responders, government, and Fortune 500 customers since 1999, selling its products through tier one wireless carriers and distributors in North America, EMEA, and Australia/New Zealand [3] Proposed Transaction - Sonim Technologies has issued an update regarding a Letter of Intent (LOI) for a proposed reverse takeover (RTO) with a private US-based company that is developing Nvidia-based High-Performance Computing (HPC) AI factories [1][2] - Upon completion of the RTO, Sonim shareholders will receive equity ownership in the combined company, currently valued at $17.5 million, with potential for future value appreciation [2] Commitment to Transparency - The announcement reflects Sonim's commitment to transparency as the transaction progresses, with further updates to be shared as more information becomes available [2]

Core Viewpoint - Sonim Technologies, Inc. has received an unsolicited, non-binding proposal from Orbic North America, LLC to acquire substantially all of its operating assets for $25 million, while also pursuing a Reverse Take Over (RTO) transaction with another private company [1][2]. Company Overview - Sonim Technologies is a leading U.S. provider of rugged mobile solutions, including phones and wireless internet data devices, designed for users requiring durability in demanding environments [3]. - The company has been trusted by first responders, government entities, and Fortune 500 companies since its inception in 1999, selling its products through tier one wireless carriers and distributors across North America, EMEA, and Australia/New Zealand [3]. Proposal Details - The proposal from Orbic North America, dated June 26, 2025, indicates that the $25 million offer would not prevent Sonim from completing the RTO transaction outlined in a recently disclosed letter of intent with a private U.S.-based company focused on Nvidia-based High-Performance Computing [1]. - The Special Committee of Sonim's Board of Directors will evaluate this proposal with the assistance of legal and financial advisors, with further updates to be provided as more information becomes available [2].

Company Overview - 10x Genomics, Inc. is a leader in single cell and spatial biology, providing integrated solutions that include instruments, consumables, and software to enhance biological research and advance human health [3]. Upcoming Event - Members of 10x Genomics' management team will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference on May 13, 2025, at 11:20 a.m. Pacific Time [1]. - A live webcast of the fireside chat will be accessible on the company's website, with an archive available for at least 30 days post-event [2]. Product Impact - The company's products are instrumental in breakthroughs across various fields such as oncology, immunology, and neuroscience, contributing to significant advancements in understanding health and disease [3]. Disclosure Practices - 10x Genomics utilizes various channels, including SEC filings, press releases, and social media, to disclose material non-public information and comply with regulatory obligations [4].